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ABSTRACT 
 
Application of siRNA in high-throughput fashion is still in its early phase although the principle has been 
established for three years. In this review, we outline the different vector-based siRNA delivery platforms as 
well as resources that are becoming available for high-throughput applications, and some initial outcomes of 
vector siRNA high-throughput screening efforts using vector encoded siRNA. It is expected that further im-
provement of the siRNA technology and availability of the siRNA resources will help to materialize the po-
tential of siRNA for functional genomics and drug target validation. 
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INTRODUCTION 
 
RNA  interference  (RNAi)  achieved  by  double-stranded 
RNA (dsRNA) mediated sequence-specific breakdown of 
the mRNA (Fire et al, 1998; Montgomery and Fire, 1998; 
Elbashir  et  al,  2001a).  It  is  an  evolutionarily  conserved 
phenomenon initially characterized in C. elegans and Dro-
sophila,  but  also  occurs  in  plants,  fungi  and  mammals 
(Boshare and Labouesse, 2000). Mechanistic studies have 
indicated that the effector molecules of the RNAi process 
is not the long dsRNA itself, but a family of short double-
stranded RNA fragments (19-21 base pairs in length) de-
rived through cleavage of the long dsRNA by RNase III 
enzyme(s)  (Elbashir  et  al,  2001b).  The  short  double-
stranded  RNA  fragments  generated  as  such,  as  well  as 
through chemical synthesis or vector-based expression, are 
collectively referred to as small interfering RNA (siRNA).  
The long dsRNA cannot be used in mammalian cells for 
gene  silencing  due  to  the  fact  that  introduction  of  long 
dsRNA elicits a strong antiviral response that obscures any 
gene-specific  silencing  effect.  Much  of  this  response  is 
caused  by  activation  of  the  dsRNA-dependent  protein 
kinase  PKR,  which  phosphorylates  and  inactivates  the 
translation initiation factor eIF2a (Proud, 1995). Introduc-
tion  of  siRNA  into  mammalian  cells  was  found  not  to 
elicit the antiviral response to such an extreme level, but 
still can result in efficient gene knockdown (Sledz et al, 
2003; Elbashir et al, 2001b). This makes siRNA widely 
applicable in various mammalian species. The mechanism 
and biological implications of RNAi are still not fully un-
derstood. 
 
Methods for generating siRNAs 
Short siRNA molecules can be prepared by direct chemi-
cal synthesis or transcription driven by RNA polymerase 
promoters. In term of high-throughput applications, vec-
tor-based strategies are favoured because such strategies 
enjoy  the advantages  of much  lower cost  and  ability  to 
regenerate. A synthetic siRNA library could be expensive 
for most researchers. The only large-scale synthetic siRNA 
library  that  was  produced  so  far  is  the  genome-wide 
siRNA collection made for Novartis by Qiagen (Hilden, 
Germany) and Dhamarcon (Lafayette, USA). Transfection 
efficiency of siRNA into cells depends on cell types and 
the RNAi effect of synthetic siRNA only sustain for a pe-
riod of time. The advantage of the vector-based siRNA is 
the capability of removing those cells that are not trans-
fected with the plasmids by selecting the transfected cells  
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with antibiotic resistant genes. Virus vectors also enable 
the delivery of siRNA expression cassettes into cells with 
higher transfection efficiency, and in case of lentivirus and 
retrovirus, it is easy to make stable knockdown cells by 
integration into the genome. If one wants to use siRNA 
expression  vectors  as  a  combinatorial  library,  the  viral 
vectors would be most suitable. In the current review, we 
will  focus  on  the  vector-based  siRNA  libraries  and  the 
methods to produce them.  
 
siRNA production by pol III promoters 
The  use  of  pol  III  promoters  in  vectors  for  encoding 
siRNA was pioneered by a number of groups in early 2002 
(Brummelkamp  et  al,  2002;  Miyagishi and  Taira,  2002; 
Sui et al, 2002; Xia et al, 2002; and Yu et al, 2002). The 
vectors  contain  a  single pol  III  promoter  followed  by  a 
segment  of  DNA  that  encodes  a  short  hairpin  RNA 
(shRNA) (Figure 1A). The shRNA closely resembles the 
structure  of  microRNAs  and  will  be  integrated  into  the 
RISC complex in the same way as the normal siRNA does. 
The backbones of these constructs were initially plasmids, 
but the grafting the shRNA expressing cassettes into dif-
ferent viral vectors such as lentivirus, retrovirus and even 
adenovirus  also  explored  successfully  to  facilitate  the 
transfection of cells that were hard to penetrate, such as 
primary cells and suspension cells (Li et al, 2003; Hosono 
et al, 2004; Devroe and Silver, 2004)  
 
Another strategy of encoding siRNA that has gain more 
popularity is a vector that contains dual pol III promoters 
arranged in a convergent manner that drive the expression 
of two short complementary RNA strand from a single 19 
bp DNA region (Figure 1B) (Chen et al, 2005; Zheng et al 
2004). While being as effective as the shRNA encoding 
vectors, these dual-promoter (GeneBuster) vectors are first 
of all more robust for cloning both because of the lack of 
secondary structure in the siRNA coding region, and much 
lower  level  of  DNA  synthesis  errors  due  to  the  shorter 
sequence, and they have tremendous advantages in con-
structing  large  scale  siRNA  libraries  in  a  combinatorial 
way, as will be discussed below. 
 
A third method is a technique using two tandem pol III 
promoters to drive the expression of siRNA from separate 
19 mer DNA fragments (Figure 1C) (Lee et al, 2002). This 
method might not be widely used due to the fact that con-
struction of such a plasmid is considerably more cumber-
some than the other two methods. This method as well as 
the shRNA method, however, offers the possibility to inte-
grate mismatches into the resulting siRNA, thus possibly 
enhance  the  efficacy  of  the  siRNA  or  increase  the  fre-
quency of effective siRNA. 
 
H1 and U6 promoters from human and mouse are the most 
widely used pol III promoters in the siRNA vector con-
struction.  Other  promoters  that  have  been  used  include 
promoters of tRNA
Val and tRNA
Met (Oshima et al, 2003; 
Boden et al, 2003). All these pol III promoters are active 
in a large variety of cells, and appear to perform similarly 
in  different  species.  This  makes  it  very  easy  to  use  the 
same vector in different experimental systems. One inter-
esting feature of the pol III promoters is that they can be 
easily  transformed  into  inducible  promoters  (van  de 
Wetering et al, 2003). This feature is very important for 
some functional studies and screening. 
 
In addition to plasmid-based systems, PCR-derived siRNA 
expression cassettes based on the single-promoter system 
have been shown to efficiently suppress gene activities in 
transfected cells (Castanotto et al, 2002). 
 
siRNA production by other promoters  
Other promoters that have been used for siRNA produc-
tion include T7 promoter and CMV promoter (Xia et al, 
2002; Holle et al, 2004). Since T7 promoter does not work 
in  mammalian  cells,  strategies  employing  T7  or  similar 
promoters normally can only support siRNA production in 
test tubes, but not within cells. People have overcome this 
shortcoming by  either  pre-load the promoter with CMV 
promoter is a much stronger promoter compared to other 
pol III promoters, and this can allow more siRNA mole-
cules to be transcribed from a given amount of DNA vec-
tor. But since CMV promoter is an RNA polymerase II 
(pol  II)  promoter,  the  resulting  transcripts  are  normally 
capped at the 5’-end and tailed at the 3’-end with a long 
poly (A) sequence. It appears that such modifications are 
well tolerated as shown in the efficacy assays.
 Due to the 
potentially higher degree of flexibility in enabling differ-
ent spatial and temporal expression patterns, these types of 
vector-based siRNA strategies might be much more useful 
for in vivo research purposes and for siRNA based gene-
therapy at a later stage although pol III based vectors seem 
to be able to satisfy most of the gene knock-down needs in 
cultured cells. 
 
Construction of siRNA libraries 
One of the critical initial steps in the high throughput siRNA 
application  is the formation  of a physical  siRNA library, 
which many people also refer to as a siRNA library.  
 
To generate a siRNA library, one critical factor to consider 
is the design of siRNA sequence. Since the first guideline 
for siRNA design was published by Tuschl and colleagues 
(Elbashir et al, 2001b) several studies of currently avail-
able  information  for  effective  and  non-effective  siRNA 
have been carried out, and these have resulted in different 
siRNA design tools that based on only partially overlap-
ping criteria (Henschel et al, 2004; Wang and Mu, 2004; 
Chalk et al, 2005). SiRNA vendors have also made their 
own siRNA design software  available  on the web.  
 
One  common  drawback  of all  currently  existing  siRNA 
design software is that they are all based on limited data 
sets about siRNA efficacy. It is anticipated that, with the 
development of high throughput siRNA construction and 
validation methods, algorithms based on randomly chosen 
siRNA will emerge to provide better predictions for func-
tional siRNA. 
 
Although a siRNA library can be constructed by chemical 
synthesis, as done by Qiagen for Novartis and more re-
cently by Dharmacon, most of the siRNA libraries cover-
ing more than a couple of thousand of genes are done by 
vector-based approaches. This is because, i) a vector-based 
siRNA library can be regenerated with minimal effort, ii) 
the constructions can be carried out in a standard molecu- 
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lar biology laboratory, and iii) a vector-based siRNA li-
brary can be much more affordable than a chemically syn-
thesized library.  
 
 
A: 
 
 
 
 
 
B: 
 
 
 
 
 
C: 
 
 
 
 
 
Figure 1. Diagrams of three general ways of encoding siRNA 
in a plasmid or viral vector. The same principles apply also in 
PCR cassettes that derive from these vectors. A, a hairpin-like 
siRNA (shRNA) is generated by transcription from a segment 
of DNA (50-60 bp in length) driven by a single promoter for 
pol III RNA polymerases. B, expression of a siRNA from a 
single 19-mer DNA fragment through transcription driven two 
“opposing” promoters for Pol III RNA polymerases. C, expres-
sion of a siRNA from a two separate 19-mer DNA fragments 
through transcription driven two “tandem” promoters for Pol 
III RNA polymerases. 
 
 
Three large-scale siRNA libraries have recently been con-
structed  by  academic  researchers  (Paddison  et  al,  2004; 
Berns et al 2004, Michiels et al, 2002) and Galapagos has 
generated  the  first  large  scale  adenovirus  based  siRNA 
library in the industrial sector. Multiple efforts have been 
initiated since then by commercial companies, and notably 
among them, Genordia AB, a Sweden-based company will 
most likely be able to deliver the first siRNA library that 
covers a whole mammalian genome in 2005. 
 
Hannon  and  colleagues  have  constructed  a  large-scale 
siRNA  library  targeting  a  selected  panel  of  human  and 
mouse  genes  using  a  hairpin  siRNA  encoding  cassette 
(Berns et al, 2004). The siRNA-encoding cassette was first 
cloned  into  a  pSHAG-Magic  donor  vector.  Although  in 
most  siRNA  applications  people  has  chosen  to  use  19-
21mer  siRNA,  this  particular  siRNA  library  encoded 
siRNA expression unit that contained 29 nucleotides, sim-
ple loop structure and U6 promoter. It was found that 29-
nucleotide hairpins were more effective than shorter hair-
pin siRNA in this study. Since the efficacy of short siRNA 
is  well  established,  this  interesting  finding  might  need 
more independent confirmation before being adopted as a 
guideline for siRNA libraries construction. Also concerns 
have been raised for possibly higher level of off-target hits 
as well as induction of antiviral responses. Totally 28,659 
shRNAs targeting 9,610 human genes and 9,119 shRNAs 
targeting 5,563 mouse genes were included in the Hannon 
siRNA library. Some characteristics of this library include: 
1)  all  clones  were  sequence  verified.  The  extensive  se-
quence  verification  was  warranted  because  25–75%  of 
cloned shRNAs were found to contain significant muta-
tions that arose during chemical synthesis. 2) Only coding 
sequences  were  targeted,  and  each  shRNA  was  chosen 
such that it contained not more than 26 bp matches to any 
other gene. It should be cautioned that recent studies have 
demonstrated that for processed siRNA sequence identity 
up to 16-17 might already allow the siRNA to have off-
target effects. 3) Where possible, shRNAs were designed 
to have sequence identity to the mouse orthologue of the 
targeted gene. In terms of gene family representation, this 
library covers about 85% of all known kinases and phos-
phatases by three or more siRNAs per gene. Most other 
functional classes contain between 30–60% coverage with 
three or more hairpins, and 80% of genes by at least one 
sequence-verified  hairpin.    A  unique  60-nuclotide  DNA 
bar code has been integrated to each vector to allow identi-
fication  of  shRNAs  in  populations  of  virally  transduced 
cells through hybridization methods. 
 
The human RNAi library (the 'NKi library') constructed by 
Bernards and colleagues contains  23,742 siRNA  vectors 
that cover 7,914 human genes (Michiels et al, 2002). Gene 
within this collection include components of major cellular 
pathways, such as the cell cycle, transcription regulation, 
stress signaling, signal transduction and important biologi-
cal  processes  such  as  biosynthesis,  proteolysis  and  me-
tabolism. In addition, genes implicated in cancer and other 
diseases are included in the library. The siRNA encoding 
DNA fragments were cloned in a high-throughput fashion 
into  pRetroSuper  (pRS),  a  previously reported retroviral 
vector containing the shRNA expression cassette. This is 
one of the first large scale siRNA collection in the aca-
demic sector and in the validation of this library, research-
ers have achieved on average 70% expression inhibition  
for approximately 70% of the genes in the library using a 
TTTT 
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pool  of  three  knockdown  vectors  against  a  single  gene.  
Compared  to  siRNA  library  made  in  plasmid  vectors, 
siRNA librarys constructed in viral vectors has to be pack-
aged and mass produced before being used in any knock-
down experiments. These might comprise a major limita-
tion in the application of viral vector based siRNA librar-
ies in very large-scale screening.  
 
Schultz and his colleagues have developed a PCR based 
system  to  generate  siRNA  for  about  8000  genes  at  2-
siRNA/gene  coverage  using  an  opposing  promoter  ap-
proach. The siRNA has been used to discover novel mem-
bers of the NF-kB pathway (Zheng et al, 2004). A single-
step PCR protocol was used to produce siRNA expression 
cassettes  in  a  high-throughput  fashion  and  showed  that 
these siRNA expression cassettes can also specifically and 
efficiently suppress the expression of both transfected and 
endogenous genes. This single-step PCR approach is effi-
cient and cost-effective and makes high-throughput  pro-
duction  of  siRNA  expression  cassette  libraries  for  ge-
nome-wide functional gene annotation practical.  The ar-
rayed library was used to screen for genes involved in the 
NF-B signalling pathway that controls many diverse cellu-
lar  processes  including  growth,  development,  inflamma-
tion, immune response, apoptosis, and oncogenesis.  
 
Notably, one of the first viral based siRNA libraries was 
generated  by  an  industrial  player,  Galapagos  Genomics. 
This  adenoviral  siRNA  library  contains  knock-down  re-
agents for over 4,900 human druggable transcripts, includ-
ing  G-protein coupled receptors  (GPCRs),  ion  channels, 
nuclear  hormone  receptors,  kinases,  phosphodiesterases 
and  other  druggable transcripts.  Three adenoviral  vector 
encoded siRNAs were designed for each gene. This three-
fold redundancy in siRNA sequences gives a 90% prob-
ability that the mRNA for any given gene will be knocked-
down by at least 75%. Such a loss-of-function gene collec-
tion provides an ideal complement to the arrayed adenovi-
ral gain-of-function libraries from the same source. Other 
characteristics of this siRNA library include: 1) the siRNA 
expression cassette is based on the human U6 promoter, a 
strong,  ubiquitously  active  promoter  that  lacks  essential 
promoter elements within the transcribed region. 2) The 
U6 promoter-based expression cassette was cloned in an 
adenoviral adapter plasmid at the position of the E1 re-
gion.  The  adenoviral  vectors  were  based  on  adenovirus 
serotype 5 with deleted E1 and E2A regions. 3) The viral 
vectors were found to be able to express processed hairpin 
RNAs for at least 10 d. 4) The adenoviral vectors used 
have a broad tropism and very efficiently infect many dif-
ferent primary cell types including primary keratinocytes 
and primary synoviocytes, two cell types that are notori-
ously  difficult  to  transfect.   The  use  of siRNA tools in 
primary cells has been hampered by inefficient transfec-
tion protocols. Advantages in the transfection aspect are of 
critical  importance  for  some  applications,  and  thus 
counter-balance the burden imposed by the cumbersome 
viral handling. 
 
siRNA libraries with degenerated sequences 
In a conventional siRNA application, a target gene is cho-
sen first, and then siRNA sequences are designed against 
the transcript of this gene. In this approach, the choice of 
gene, and choice of targeting sites are inevitably  biased 
due to the limited number of genes and sites that can be 
included in a particular study. The bias also arise inevita-
bly from the fact that we have just started to get a rela-
tively complete picture of the part of the mouse transcrip-
tome that has a poly (A) tail, and knowing little about tran-
scripts that do not have a such a tail. The development of 
siRNA  expressing  libraries  that  encode  substantially  all 
permutations of 19-mer siRNA thus become an appealing 
approach to allow the use of it as a single affordable tool 
for un-biased genome-wide screening. 
 
Towards this direction, siRNA libraries have been synthe-
sized by integration of 19-mer fully randomized DNA se-
quences into different siRNA encoding vectors (Chen et 
al, 2005). Such vectors should have theoretical complexity 
of  2.75x10
11  in  order  to  encode  all  the  permutations  of 
siRNA. This is a complexity that, albeit being reachable, 
will impose significant burden on the manipulation of the 
library  and  use  of  it  for  screening.  Lucky  or  not,  the 
siRNA was actually found to be tolerant to mismatches 
towards its terminus. This makes it reasonable to assume 
that a library will about 1 x 10
9 complexity will cover all 
possible siRNA. Such a complexity then comes in a range 
that is practical for plasmid library construction and main-
tenance.    The  library  was  used  for  phenotype-driven 
screening using cell proliferation as a model, and multiple 
siRNA  that  can  induce  significant  enhancement  of  cell 
growth were identified. 
 
Another alternative approach is to generate semi-random 
siRNA library from an mRNA source. In this case, a spe-
cific mRNA population is converted into double stranded 
cDNA, which will be cut into short DNA fragments that 
can then inserted into the vectors for encoding siRNA. The 
advantage of this type of libraries is that it will only have a 
complexity of in the neighborhood of 10
6 but already be 
able to cover a substantial part of the genome. The limiting 
aspect of the approach is that a library made in this way 
will only be useful for the same organism, or even only for 
the same cell type, whereas other fully randomized librar-
ies can be used in all cell types and all relevant organisms. 
There have been several reports (Luo et al, 2004; Sen et al, 
2004;  Shirane  et  al,  2004)
  for  the  construction  of  such 
semi-random siRNA libraries and one of these is briefly 
described  here  as an example  (Sen  et  al,  2004). In  this 
method, mRNA is converted into double-stranded cDNA 
mixture that  was further cleaved with a  mixture  of five 
restriction endonucleases, each  of which leaves a 5'-CG 
overhang but  has  a  different  4-bp recognition sequence. 
This combination covers 6 of 256 possible 4-bp sequences, 
resulting in one cleavage every 43 bp. These fragmented 
cDNAs are ligated to a hairpin linker with a complemen-
tary 5'-CG overhang. This hairpin has a recognition site 
for MmeI, a type II restriction endonuclease that cleaves 
20–21 bp away from its recognition sequence and leaves a 
two-base 5' overhang. A hairpin linker is then ligated to 
either the 5' or 3' end of the double-stranded cDNA frag-
ment. Next an "extension linker" comprised of three dif-
ferent  oligonucleotides  is  ligated  to  the  cDNA-extended 
hairpin. As a result the 5' and 3' ends of the extended hair-
pin become ligated to the extension "sense" oligonucleo-
tide (green) and the extension "antisense" oligonucleotide  
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respectively. The extension priming oligonucleotide serves 
as primer for DNA elongation by the highly processive Bst 
DNA polymerase large fragment, which lacks a 5'–3' ex-
onuclease domain. This reaction converts the hairpin into a 
dsDNA that encodes a hairpin RNA. The process has been 
used to construct a siRNA library from a mouse embryo 
cDNA library. This resulted in three million independent 
clones. Twenty-seven clones were chosen at random for 
sequencing, all of which revealed matches against known 
mouse genes.  Five random clones were used to generate 
stable NIH 3T3 cell lines. Northern blotting with probes 
corresponding  to  their  mRNA  targets  demonstrated  that 
each of the cDNA-derived inserts produced the expected 
processed 21-base siRNAs and these clones caused spe-
cific reductions in their corresponding target mRNA.  
 
Functional screening using different siRNA libraries 
Genome-wide RNAi screens were explored in C. elegans 
using libraries of in vitro-transcribed long dsRNAs or sim-
ply  the  bacteria  that  express  dsRNA.  For  example,  an 
RNAi feeding library consisting of 16,757 bacterial clones 
covering majority  of the worm genome was constructed 
(Fraser et al, 2000; Kamath et al, 2003). Upon feeding the 
worms,  these  clones  generated  transient  loss-of-function 
phenotypes  for  many  genes  by  inactivating  the  target 
genes  via  RNAi.  Genome-wide  RNAi  approaches  have 
been used successfully for phenotype-based screens also in 
Drosophila melanogaster. In part, these successes derived 
from the availability of convenient and inexpensive meth-
ods for producing and introducing dsRNA. To date, the 
use of RNAi libraries in mammalian systems is becoming 
well accepted but most of the work has been limited to 
specific protein families because of technical and practical 
issues  associated  with  generating  large  synthetic  siRNA 
and/or vector-based short hairpin RNA (shRNA) expres-
sion libraries, but the situation is rapidly improving with 
the technology development mentioned above. Screening 
schemes  using  large-scale  siRNA  libraries  are  under-
standably diverse due to differences in aims, vector sys-
tems,  and  read-out  methods.  The  five  case  studies  pre-
sented below could give us a hint about how such libraries 
can be deployed in HTS. 
 
Retroviral vectors can be used to transfect a large variety 
of cell types, and its short-coming on the handling side can 
be well balanced by using it in a combinatorial manner, 
e.g., in libraries. Work done by Berns et al (2004) has pro-
vided a typical example of such applications in a medium 
scale. In this study, retroviral vectors were  generated in 
pools and then the pools were used to transfect BJ-TERT-
tsLT cells at 32 °C. After two days’ incubation at 32 °C, 
the incubation temperature was increased to 39 °C for pro-
liferating  colony  screening.  In  the  first-round  screening, 
six pools of infected cells were found able to form colo-
nies at  39°C.  These shRNA inserts were then re-cloned 
from these colonies, and their identity was established by 
DNA sequence analysis. Only those shRNA inserts that 
were presented in multiple independently derived colonies 
were further analyzed in the second-round screening in BJ-
TERT-tsLT  fibroblast.  Using  this  approach,  shRNAs 
against six genes were identified that could suppress the 
temperature-shift-induced  proliferation  arrest  in  the  BJ-
TERT-tsLT  cells.  Remarkably  one  identified  gene  was 
p53,  which  underscores  the  quality  of  the  NKi  library. 
Knockdown of other five identified genes also mediated 
escape  from  proliferation  arrest  in  BJ-TERT-tsLT  cells 
when tested in the absence of retroviral vector, suggesting 
that inhibition of these genes allowed bypass of the p53 
response.  In screening as such, it would always be a con-
cern whether the change in read-out is a consequence of 
on-target hit or off-target hits. In this case, it was found 
that two of the three shRNAs targeting a single gene could 
mediate  escape from  growth  arrest  for  three  of  the  five 
newly identified genes. This could be considered as a con-
firmation that the effects of the siRNAs were 'on-target'. 
For genes that only have a single siRNA hit, normally ad-
ditional siRNA need to be designed to confirm any pheno-
typical changes observed with the initial siRNA clone.  
 
In a similar screening, 6712 shRNA expression targeting 
4873 genes were used to discover novel members of pro-
teasome. The 26S proteasome is the major non-lysosomal 
protease  in  eukaryotic  cells.  To  search  the  library  for 
shRNAs that compromise proteasome function, a reporter 
assay was used in which a fluorescent protein (Zoanthus 
green fluorescent, ZsGreen) was coupled to a well charac-
terized degradation signal, the mouse ornithine decarboxy-
lase (MODC) gene. Another plasmid encoded Discosoma 
red fluorescent protein (DsRed) was used as a normaliza-
tion  control  for  transfection.  Individual  transfection  of 
6,712  shRNAs  revealed  approximately  100  RNAi  con-
structs  that  increased  the  accumulation  of  ZsGreen–
MODC, of which 22 corresponded to 15 known protea-
some subunits.  
 
As mentioned above, a siRNA expression cassette library 
targeting  8,000  human  genes  from  the  public  UniGene 
library were generated in Schultz lab in Scripps Institute in 
a vector containing dual pol III promoters, with two target-
ing sequences per gene Zheng et al, 2004). To screen for 
regulators  of NF-kB  transcriptional  activation  by  TNFa, 
the  pNF-B-Luc  reporter  plasmid  was  cotransfected  with 
individual  siRNA  expression  cassettes  into  HEK293T 
cells. Of 94 genes identified in the initial screening, 20 hits 
were further assessed by introducing additional siRNAs, 
and  17  of  them  seemed  to  be  genuine  on-target  hits. 
Among them, eight are known to be involved in the NF-
kB signalling. Of the remaining genes, some might be in-
volved in cellular processes that indirectly affect the NF-B 
pathway, whereas others might have previously unrecog-
nized roles in the NF-B signalling pathway.   
 
All screening work mentioned above were done in microti-
tre plates, which will remain a major screening platform in 
the future. Cell microarrays were created to provide much 
higher throughput than microtitre plates for siRNA based 
screening. Cell microarray was first described by Ziauddin 
and Sabatini
 (2001) who demonstrated that cells grown on 
a glass substrate could take up DNA–lipid complexes that 
had been deposited on the slide before cells were plated. 
Cells  became  transfected  in  situ,  with  defined  spots  of 
transfected  cells  localized  over  the  printed  DNAs.  Cell 
microarrays represent a novel alternative to classical ap-
proaches to phenotype-based assays in mammalian cells, 
at least for some of the easy-to-transfect cells such as HEK 
293T,  IMR90/E1A,  NIH  3T3,  and  HeLa  cells.  In  this  
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screening format, siRNA (plasmids or PCR cassettes) are 
spotted  onto  glass  slides  together  with  transfection  re-
agents (normally with gelatin too for immobilization pur-
pose). The vector based siRNA reagents appear to be sta-
ble for months on such chips. When cells are overlaid on 
top of a spot on the slides, corresponding siRNA vector 
will  be  taken  into  the  cells  so  that  siRNA  will  be  ex-
pressed, and the effect of the siRNA can be read out in 
high  throughput  according  to  the  phenotypes  or  the  re-
porter  systems  used.  The  initial  proof-of  principle  was 
done  by  siRNAs  corresponding  to  the  enhanced  Green 
Fluorescent  Protein  (GFP)  gene  (eGFP)  on  microscope 
slides,  and  plated  HeLa  cells  permanently  expressing  a 
destabilized version of eGFP on top of the slides. The re-
sult showed the cellular uptake, "reverse transfection", of 
rhodamine-tagged siRNA (rh-eGFP), and silencing of GFP 
expression in cells. An experimental comparison was pro-
vided by carrying out, side by side, the array-based and 
microtitre plate screening of siRNA that can perturb pro-
teosome  functions.  The  result  showed  that  the  array 
method does work in screening for siRNA that can ma-
nipulate endogenous genes, and likely to provide data that 
is  even  better  than  the  classic  microtitre  plate  based 
screening process. Advantage of the method is that large 
number  of  siRNA  can  be  rapidly  screening  through  a 
given phenotype or reporter system. The limitation of the 
method is, in additional to the need of complex instrumen-
tation, that many phenotypes can’t be fit into such an ar-
ray-based read-out format.  
 
CONCLUSIONS 
 
RNAi provides a perfect example of how a natural occur-
ring process can be “hijacked” by researchers and used as 
a research tool. The penetration speed of this technology 
into the labs in both academic and industrial settings has 
been astonishing even though the mechanism of RNAi has 
not been fully understood. In this reveal, we tried to focus 
on the development and application of vector based siRNA 
libraries due to that fact that although synthetic siRNA has 
become  much  more  affordable  now  than two  years  ago 
due to stiff competition and improvement in the through-
put of RNA synthesis, vector-based siRNA will still be the 
reagent of choice for large scale siRNA based screening in 
most academic institutions and companies. It is worth to 
stress  that  synthetic  siRNA  has  also  certain  advantages 
over  vector-based  siRNA  approaches  in  dosing,  integra-
tion of modified nucleotides, and delivery, in just name a 
few aspects for example. 
 
It is anticipated that plasmid libraries that have a  ge-
nome-wide coverage will become available in 2005 for 
screening  using  both  transient  transfection  as  well  as 
stable  transfections.  Inducible  promoters  will  be  inte-
grated into some of the libraries for special screening 
need. While lentivirus and other  viral vectors provide 
obvious  advantages  in  the  transfection  of  hard-to-
transfect cells, they are bound to be significantly cum-
bersome to work with in a high throughput screening. It 
is more likely that they will serve as second line of veri-
fication  tools  instead  of  being  used  as  the  first  line 
screening tools in many occasions other than combina-
torial screening.  
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